ProGenis Pharmaceuticals has executed into a Patent Assignment Agreement with Murdoch University, Western Australia towards developing Novel Treatment for Duchenne muscular dystrophy (DMD) and Multiple sclerosis (MS).
ProGenis Pharmaceuticals has executed into a Patent Assignment Agreement with Murdoch University, Western Australia towards developing Novel Treatment for Duchenne muscular dystrophy (DMD) and Multiple sclerosis (MS).
*By submitting your information, you are granting us permission to email you. You may unsubscribe at any time.